Reducing cytotoxic action of the preservative employed in ophthalmic hypotensive medications with tear replacement therapy

Close metadata

Purpose: to assess the possibilities of reducing the cytotoxic effect of benzalkonium chloride (a preservative used in ophthalmic hypotensive drugs) with the help of tear replacement therapy. Material and methods. The study included 28 patients (56 eyes) who had been using antiglaucomatous drugs containing benzalkonium chloride as a preservative for various periods (from 2 months to 17 years). The examination was performed in the setting of compensated IOP. In addition to hypotensive topical medication regimen, all patients were prescribed Stilavit eye drops. Subjects were examined prior to the prescription of artificial tears and after 1, 3 and 6 months of its usage. Effectiveness of the treatment was evaluated with biomicroscopy, Norn’s test, Jones test, tearscopy, OCT-meniscometry, confocal microscopy, and impression cytology. Results. The use of «Stilavit» artificial tears in combination with antiglaucoma drugs led to an improvement of the corneal epithelium condition in 85% of cases, a statistically significant increase in the mean values of precorneal tear film rupture time after 1, 3 and 6 months by 26%, 61.2% and 85.8% respectively. Maximum increase of main tear production level was achieved after 3 months of treatment (increased by 43.5%), and was accompanied by 18.6% rise of the lower tear meniscus height after 3 months; in 6 months it raised by 29.4%. A tendency for restoration of the lipid layer of the tear film was observed. According to confocal microscopy and impression cytology, positive dynamics in the condition of corneal epithelium and conjunctival epithelial layer were present. Conclusion. The study results justify the use of tear replacement therapy, in particular the tear substitute Stilavit, as an additional protective agent for glaucoma treatment regimen.

Keywords:

glaucoma

cornea

dry eye syndrome

artificial tears

Authors:

Egorova G.B.

FGBU "NII glaznykh bolezneĭ" RAMN, Moskva

Averich V.V.

Research Institute of Eye Diseases, 11A Rossolimo St., Moscow, Russian Federation, 119021

List of references:

Toda I, Asano-Kato N, Komai-Hori Y, Tsubota K. Dry eye after laser in situ keratomileusis. American Journal of Ophthalmology. 2001;132:1-7. https://doi.org/10.1016/s0002-9394(01)00959-x
Astakhov SYu, Tkachenko NV. Trehalose efficacy in dry eye syndrome treatment after phacoemulsification. Oftal’mologicheskie vedomosti. 2016;9(4):79-89. (In Russ.) https://doi.org/10.17816/ov9479-89
Smirennaya EV, Mityagina ON, Rybintseva LV. The prediction of moderate-to-severe dry eye after laser refractive surgery for myopia. Kataraktal’naya i refrakcionnaya hirurgiya. 2016;16(4):50-60. (In Russ.)
Erichev VP, Ambartsumyan KH. The preservatives and secondary dry eye syndrome in long-term topical open-angle glaucoma therapy. Nacional’nyj zhurnal Glaukoma. 2011;2:59-66. (In Russ.)
Brzeski VV, Egorova GB, Egorov EA. Sindrom «suhogo glaza» i zabolevaniya glaznoj poverhnosti: klinika, diagnostika, lechenie. M.: GEOTAR-Media; 2016. (In Russ.)
Brzheskij VV, Radukhan M. Glaucoma and the dry eye syndrome. Oftal’mologicheskie vedomosti. 2014;7(2):37-49. (In Russ.) https://doi.org/10.17816/ov2014237-49
Egorov EA, Brzheskij VV, Muratova NV. Undesirable effects of ophthalmohypotensive therapy: dry eye syndrome. Novosti glaukomy. 2009;(3):3-5. (In Russ.)
Muratova NV. The diagnostic and treatment of dry eye syndrome in patients using beta-blockers. Klinicheskaya oftal’mologiya. 2003;1:4-6. (In Russ.)
Ohtsuki M, Yokoi N, Morti K, et al. Adverse effects of beta-blocker eye-drops on the ocular surface. Nippon Gakkai Zasshi. 2001;105(3):49-54. https://doi.org/10.1016/s0021-5155(01)00395-1
De Saint Jean M, Brignole F, Bringuier AF, Bauchet A, Feldmann G, Baudouin C. Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells. Invest Ophthalmol Vis Sci. 1999;40(3):619-630.
Obrink B, Wasterson A. Nature of interaction of chondroitin 4 sulphate and chondroitin sulphate — proteoglycan with collagen. Biochem J. 1971;121: 227-233. https://doi.org/10.1042/bj1210227
Pauly A, et al. New tools for the evaluation of toxic ocular surface changes in the rat. Investigative ophthalmology & visual science. 2007;48(12):5473-5483. https://doi.org/10.1167/iovs.06-0728
Pisella PJ, et al. Comparison of the effects of preserved and unpreserved formulations of timolol on the ocular surface of albino rabbits. Ophthalmic research. 2000;32(1):3-8. https://doi.org/10.1159/000055579
Erichev VP, Ambartsumyan KH, Fedorov AA. Clinical and morphological evidence of the effect of preservatives on the eye surface in primary open-angle glaucoma. Nacional’nyj Zhurnal Glaukoma. 2014;13(4):13-22. (In Russ.)
Dart J. Corneal toxicity: the epithelium and stroma in iatrogenic and factitious disease. Eye. 2003;17(8):886-892. https://doi.org/10.1038/sj.eye.6700576
Guenoun JM, et al. In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells. Investigative ophthalmology & visual science. 2005;46(7):2444-2450. https://doi.org/10.1167/iovs.04-1331
Pisella PJ, Pouliquen P, Baudouin C. Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. British Journal of Ophthalmology. 2002;86(4):418-423. https://doi.org/10.1136/bjo.86.4.418
Rolando M, et al. The effect of different benzalkonium chloride concentrations on human normal ocular surface: a controlled prospective impression cytology study. The Lacrimal System. Amsterdam: Kagler & Ghedini; 1991.
Cohen GM. Caspases: the executioners of apoptosis. Biochemical Journal. 1997;326(1):1-16. https://doi.org/10.1042/bj3260001
Debbasch C, Brignole F, Pisella PJ, Warnet JM, Rat P, Baudouin C. Quaternary ammoniums and other preservatives’ contribution in oxidative stress and apoptosis on Chang conjunctival cells. Invest Ophthalmol Vis Sci. 2001;42(3):642-652. https://doi.org/10.1016/s0002-9394(01)01036-4
Lebedev OI, Kalizhnikova EA, Yavorsky AE. Mechanisms of action and effects of the benzalkonium chloride on eye tissues. Klinicheskaya oftal’mologiya. 2013;2:63-66. (In Russ.)
Ang LPK, Tan DTH, Beuerman RW, Lavker RM. Ocular surface epithelial stem cells: implications for ocular surface homeostasis. Dry eye and ocular surface disorders. 2004;225-246. https://doi.org/10.1201/b14144-12
Egorova GB, Erichev VP, Subbot AM, Fedorov AA, Nesterova TV, Gabashvili AN, Averich VV. Evaluation of Stillavit artificial tears potential in reducing the toxic effect of benzalkonium chloride-containing hypotensive instillations on primary cell culture of the corneal limbus (experimental study). Nacional’nyj zhurnal Glaukoma. 2017;16(4):31-36. (In Russ.)
Rybakova EG, Egorova GB, Kalinich NI. Corneregel — new stimulator of reparative regeneration. Klinicheskaya oftal’mologiya. 2001;2(4):162-164. (In Russ.)
Egorov EA, Kalinich NI, Kiyasov AP. New stimulants of reparative regeneration of the cornea. Vestnik oftal’mologii. 1999;115(6): 13-16. (In Russ.)
Takhchidi EKh, Gorbunova KS. Sulfated glycosaminoglycans in ophthalmology. Vestnik OGU. 2012;148(12):201-204. (In Russ.)
Egorov EA. Hyaluronic acid: it’s usage in ophthalmology and in treatment of dry eye syndrome. Klinicheskaya oftal’mologiya. 2013;2:71-73. (In Russ.)
Egorova GB, Fedorov AA, Mitichkina TS. Potential of impression cytology in diagnosis and evaluation of efficacy of pharmacological correction of dry eye syndrome associated with contact lens wearing. Vestnik oftal’mologii. 2012; 128(1):33-35. (In Russ.)
Egorova GB, Fedorov AA, Mitichkina TS, Shamsutdinova AR. Changes of conjuntival epithelial layer in patients with intolerance of contact lenses according to a data of impression cytology. Klinicheskaya oftal’mologiya. 2014;1:17-19. (In Russ.)

Close metadata